HomeInsightsStock Comparison

Chandra Bhagat Pharma Ltd vs Sanofi Consumer Healthcare India Ltd Stock Comparison

Chandra Bhagat Pharma Ltd vs Sanofi Consumer Healthcare India Ltd Stock Comparison

Last Updated on: May 01, 2025

Key Highlights

  • The Latest Trading Price of Chandra Bhagat Pharma Ltd is ₹ 60 as of 17 Apr 15:30.
  • The P/E Ratio of Chandra Bhagat Pharma Ltd changed from 95.2 on March 2020 to 0 on December 2024 . This represents a CAGR of -100.00% over 7 yearsThe P/E Ratio of Sanofi Consumer Healthcare India Ltd changed from 62.6 on December 2024 to 62.6 on December 2024 . This represents a CAGR of 0.00% over 1 years.
  • The Market Cap of Chandra Bhagat Pharma Ltd changed from ₹ 30.18 crore on March 2020 to ₹ 0 crore on December 2024 . This represents a CAGR of -100.00% over 7 yearsThe Market Cap of Sanofi Consumer Healthcare India Ltd changed from ₹ 11347 crore on December 2024 to ₹ 11347 crore on December 2024 . This represents a CAGR of 0.00% over 1 years.
  • The revenue of Chandra Bhagat Pharma Ltd for the Mar '24 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Sanofi Consumer Healthcare India Ltd for the Mar '24 is ₹ 175.7 crore as compare to the Dec '24 revenue of ₹ 164.1 crore. This represent the growth of 7.07%.
  • The ebitda of Chandra Bhagat Pharma Ltd for the Mar '24 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Sanofi Consumer Healthcare India Ltd for the Mar '24 is ₹ 64.2 crore as compare to the Dec '24 ebitda of ₹ 66.1 crore. This represent the decline of -2.87%.
  • The net profit of Chandra Bhagat Pharma Ltd changed from ₹ 0 crore to ₹ 0 crore over 5 quarters. This represents a CAGR of 0.0% The net profit of Sanofi Consumer Healthcare India Ltd changed from ₹ 45 crore to ₹ 44.3 crore over 5 quarters. This represents a CAGR of -1.25% .
  • The Dividend Payout of Chandra Bhagat Pharma Ltd changed from 0 % on March 2020 to 0 % on December 2024 . This represents a CAGR of 0.0% over 7 yearsThe Dividend Payout of Sanofi Consumer Healthcare India Ltd changed from 0 % on March 2020 to 0 % on December 2024 . This represents a CAGR of 0.0% over 7 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Chandra Bhagat Pharma Ltd

  • Chandra Bhagat Pharma Limited was incorporated as a Private Limited Company with the name 'Chandra Bhagat Pharma Private Limited' at Mumbai on March 10, 2003.
  • Consequent upon the conversion of the Company from Private Limited Company to Public Limited Company, the name of the Company was changed to 'Chandra Bhagat Pharma Limited' on March 20, 2019. The Company incorporated in March, 2003 by Mr. Hemant Bhagat and Late.
  • Shree Chandravadan Bhagat.
  • On April 1, 2003, the Company acquired the going concern business of M/s.
  • Chandra Bhagat Corporation, partnership firm along with all its assets and liabilities.

About Sanofi Consumer Healthcare India Ltd

  • Sanofi Consumer Healthcare India Limited was incorporated on May 10, 2023, pursuant to a Certificate of Incorporation, issued by the Registrar of Companies, Central Registration Centre.
  • Pursuant to the Scheme becoming effective, the Consumer Healthcare Division (CHC) business of Sanofi India Limited (SIL) got demerged into the Company as a going concern through the Scheme of Arrangement and became effective from June 1, 2024.
  • In terms of the said Scheme, the Company allotted 23,030,622 Equity Shares to the eligible shareholders of Sanofi India Limited (SIL) upon the demerger.

Chandra Bhagat Pharma Ltd News Hub

News

Chandra Bhagat Pharma schedules board meeting

Chandra Bhagat Pharma will hold a meeting of the Board of Directors of the Company on 13 N...

Read more

11 Nov 2024 13:48

News

Chandra Bhagat Pharma to conduct AGM

Chandra Bhagat Pharma announced that the Annual General Meeting (AGM) of the company will ...

Read more

13 Sep 2024 11:49

News

Chandra Bhagat Pharma schedules AGM

Chandra Bhagat Pharma announced that the Annual General Meeting (AGM) of the company will ...

Read more

13 Sep 2024 11:41

News

Chandra Bhagat Pharma to declare Quarterly Result

Chandra Bhagat Pharma will hold a meeting of the Board of Directors of the Company on 30 M...

Read more

28 May 2024 15:32

News

Chandra Bhagat Pharma to declare Quarterly Result

Chandra Bhagat Pharma will hold a meeting of the Board of Directors of the Company on 9 No...

Read more

06 Nov 2023 20:02

News

Chandra Bhagat Pharma AGM scheduled

Chandra Bhagat Pharma announced that the 20th Annual General Meeting (AGM) of the company ...

Read more

11 Sep 2023 11:28

Sanofi Consumer Healthcare India Ltd News Hub

News

Sanofi Consumer Healthcare India to convene board meeting

Sanofi Consumer Healthcare India will hold a meeting of the Board of Directors of the Comp...

Read more

26 Apr 2025 10:37

News

Sanofi Consumer Healthcare CFO Maithilee Mistry resigns

According to an exchange filing, Mistry has decided to resign to explore new opportunities...

Read more

07 Apr 2025 12:44

News

Sanofi Consumer Healthcare India AGM scheduled

Sanofi Consumer Healthcare India announced that the 2nd Annual General Meeting(AGM) of the...

Read more

26 Mar 2025 17:41

News

Board of Sanofi Consumer Healthcare India recommends final dividend

Sanofi Consumer Healthcare India announced that the Board of Directors of the Company at i...

Read more

21 Feb 2025 09:40

News

Sanofi Consumer posts PAT of Rs 46 crore in Q3

Total operating expenditure rose by 13.8% YoY to Rs 111.50 crore in Q3 FY25, due to higher...

Read more

21 Feb 2025 10:34

News

Sanofi Consumer Healthcare India to declare Quarterly Result

Sanofi Consumer Healthcare India will hold a meeting of the Board of Directors of the Comp...

Read more

15 Feb 2025 11:22

SWOT Analysis Of Chandra Bhagat Pharma Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Sanofi Consumer Healthcare India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Chandra Bhagat Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Chandra Bhagat Pharma Ltd and Sanofi Consumer Healthcare India Ltd

Which company has a larger market capitalization, Chandra Bhagat Pharma Ltd or Sanofi Consumer Healthcare India Ltd?

Market cap of Chandra Bhagat Pharma Ltd is 45 Cr while Market cap of Sanofi Consumer Healthcare India Ltd is 11,382 Cr

What are the key factors driving the stock performance of Chandra Bhagat Pharma Ltd and Sanofi Consumer Healthcare India Ltd?

The stock performance of Chandra Bhagat Pharma Ltd and Sanofi Consumer Healthcare India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Chandra Bhagat Pharma Ltd and Sanofi Consumer Healthcare India Ltd?

As of May 1, 2025, the Chandra Bhagat Pharma Ltd stock price is INR ₹60.0. On the other hand, Sanofi Consumer Healthcare India Ltd stock price is INR ₹4942.35.

How do dividend payouts of Chandra Bhagat Pharma Ltd and Sanofi Consumer Healthcare India Ltd compare?

To compare the dividend payouts of Chandra Bhagat Pharma Ltd and Sanofi Consumer Healthcare India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions